Intended for healthcare professionals

  1. Research
  2. Drug treatments for...
  3. Drug treatments for covid-19: living systematic review and network meta-analysis
CCBYNC Open access
Research

Drug treatments for covid-19: living systematic review and network meta-analysis

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2980 (Published 30 July 2020) Cite this as: BMJ 2020;370:m2980

Data supplement

Related articles

PracticeA living WHO guideline on drugs for covid-19

See more

Cited by...

  • Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis
  • Effectiveness and safety of ivermectin in the treatment of COVID-19: protocol for a systematic review and meta-analysis
  • metaCOVID: An R-Shiny application for living meta-analyses of COVID-19 trials
  • NUTRITIONAL IMMUNITY, ZINC SUFFICIENCY AND COVID-19 MORTALITY IN SOCIALLY SIMILAR EUROPEAN POPULATIONS
  • The association between immunosuppressants use and COVID-19 adverse outcome: National COVID-19 cohort in South Korea
  • Antibody response in individuals affected with Sars-Cov-2 infection: temporal trends and qualitative and quantitative differences in symptomatic and asymptomatic subjects. A Cross Sectional Analysis. Ab-Covid Study
  • Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: cohort study in OpenSAFELY using linked primary care, secondary care and death registration data
  • Tocilizumab and sarilumab alone or in combination with corticosteroids for COVID-19: A systematic review and network meta-analysis
  • Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis
  • Tocilizumab in COVID-19 - A Bayesian reanalysis of RECOVERY
  • Diagnostic et traitement du syndrome de detresse respiratoire aigue
  • A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants
  • Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
  • Diagnosis and management of acute respiratory distress syndrome
  • Socioeconomic Status and COVID-19 Related Outcomes in India: Hospital Based Study
  • A population-level analysis of the protective effects of androgen deprivation therapy against COVID-19 disease incidence and severity
  • We need clinical guidelines fit for a pandemic
  • Prophylaxis against covid-19: living systematic review and network meta-analysis
  • A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report
  • The Effect of Famotidine on Hospitalized Patients with COVID-19: a Systematic Review and Meta-analysis
  • Current evidence for COVID-19 therapies: a systematic literature review
  • Researcher broke embargo to leak BMJ paper to Trump administration
  • Prophylaxis for covid-19: living systematic review and network meta-analysis
  • Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
  • Controlling the first wave of the COVID-19 pandemic in Malawi: results from a panel study
  • Missed opportunities of flu vaccination in Italian target categories: insights from the online EPICOVID 19 survey
  • Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
  • Urban Sprawl of Covid-19 Epidemic in India: Lessons in the First Semester
  • High-altitude is associated with better short-term survival in critically ill COVID-19 patients admitted to the ICU
  • A Systematic Review and Network Meta-Analysis for COVID-19 Treatments
  • Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis
  • Current evidence for COVID-19 therapies: a systematic literature review
  • Development and assessment of the performance of a shared ventilatory system that uses clinically available components to individualize tidal volumes
  • Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining methodological quality
  • Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
  • COVID-19 neutralizing antibodies predict disease severity and survival
  • Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
  • Covid-19: We need to understand the risks to tackle them
  • A living WHO guideline on drugs for covid-19
  • Living systematic reviews at The BMJ
  • Remdesivir for severe covid-19: a clinical practice guideline
  • Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds
Back to top